within Pharmacolibrary.Drugs.S_SensoryOrgans.S01A_Antiinfectives.S01AX06_Resorcinol;

model Resorcinol
  extends Pharmacolibrary.Drugs.ATC.S.S01AX06;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>S01AX06</td></tr><td>route:</td><td>ophthalmic</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Resorcinol is a dihydroxybenzene derivative used topically in dermatology for its antiseptic, disinfectant, and keratolytic properties, commonly found in acne and eczema preparations. It is rarely used systemically and is not approved for systemic administration; its use is mainly restricted to topical formulations and some ophthalmic solutions.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters for resorcinol are not directly reported in available publications for its ophthalmic or topical use in humans; estimates are based on physicochemical properties and analogous phenolic compounds.</p><h4>References</h4><ol><li><p>Silverberg, JI, et al., &amp; McHale, KA (2024). Tapinarof validates the aryl hydrocarbon receptor as a therapeutic target: A clinical review. <i>The Journal of allergy and clinical immunology</i> 154(1) 1–10. DOI:<a href=&quot;https://doi.org/10.1016/j.jaci.2023.12.013&quot;>10.1016/j.jaci.2023.12.013</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/38154665/&quot;>https://pubmed.ncbi.nlm.nih.gov/38154665</a></p></li><li><p>Roman, D, et al., &amp; Kluwe, W (2016). Ocular toxicity of AUY922 in pigmented and albino rats. <i>Toxicology and applied pharmacology</i> 309 55–62. DOI:<a href=&quot;https://doi.org/10.1016/j.taap.2016.08.025&quot;>10.1016/j.taap.2016.08.025</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/27576608/&quot;>https://pubmed.ncbi.nlm.nih.gov/27576608</a></p></li><li><p>Baldwin, RS, et al., &amp; Terry, MK (1983). Zeranol: a review of the metabolism, toxicology, and analytical methods for detection of tissue residues. <i>Regulatory toxicology and pharmacology : RTP</i> 3(1) 9–25. DOI:<a href=&quot;https://doi.org/10.1016/0273-2300(83)90046-6&quot;>10.1016/0273-2300(83)90046-6</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/6351181/&quot;>https://pubmed.ncbi.nlm.nih.gov/6351181</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Resorcinol;
